NEW YORK ( TheStreet) -- Jazz Pharmaceuticals (Nasdaq: JAZZ) hit a new 52-week high Friday as it is currently trading at $51.55, above its previous 52-week high of $51.36 with 651,864 shares traded as of 11:35 a.m. ET. Average volume has been 766,900 shares over the past 30 days. Jazz has a market cap of $1.94 billion and is part of the health care sector and drugs industry. Shares are up 25.7% year to date as of the close of trading on Thursday. Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products to meet unmet medical needs. The company has a P/E ratio of 19.1, above the average drugs industry P/E ratio of 18.5 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter